{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:24:24Z","timestamp":1785187464734,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2026.1754350","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:42:18Z","timestamp":1769496138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: The role of cannabinoids and the endocannabinoid system in anti-cancer therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Lirit N.","family":"Franks","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine","place":["Salt Lake City, UT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Raup-Konsavage","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Experimental Therapeutics, The Pennsylvania State University College of Medicine","place":["Hershey, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO) and Associate Laboratory i4HB, Biochemistry Laboratory, Faculty of Pharmacy, University of Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","article-title":"Assessment of cancer patients' attitudes toward holistic complementary and alternative medicine and factors influencing these attitudes","author":"Aycil","year":"2025","journal-title":"Altern. Ther. Health Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12885-023-11792-4","article-title":"A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial","volume":"24","author":"Bhaskaran","year":"2024","journal-title":"BMC Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/cells10061282","article-title":"The interplay between the immune and the endocannabinoid systems in cancer","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI16116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"J. Clin. Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1158\/1078-0432.CCR-08-0799","article-title":"Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells","volume":"14","author":"Cianchi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/27683605251377417","article-title":"Impact of medical cannabis on the quality of life of cancer patients: a critical review","author":"Correa","year":"2025","journal-title":"J. Integr. Complement. Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"982082","DOI":"10.3389\/fimmu.2022.982082","article-title":"Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours","volume":"13","author":"Dada","year":"2022","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"29668","DOI":"10.18632\/oncotarget.9408","article-title":"Novel role of cannabinoid receptor 2 in inhibiting EGF\/EGFR and IGF-I\/IGF-IR pathways in breast cancer","volume":"8","author":"Elbaz","year":"2017","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13105-018-0611-7","article-title":"Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis","volume":"74","author":"Fonseca","year":"2018","journal-title":"J. Physiol. Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00520-025-09763-5","article-title":"Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol","volume":"33","author":"Hardy","year":"2025","journal-title":"Support Care Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ijc.31030","article-title":"G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1","volume":"142","author":"Hasenoehrl","year":"2018","journal-title":"Int. J. Cancer"},{"key":"B5","article-title":"Cannabis (Marijuana) and Cannabinoids: What You Need To Know","year":"2025","journal-title":"Natl. Cent. Compliment. Integr. Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/onc.2010.502","article-title":"The putative cannabinoid receptor GPR55 promotes cancer cell proliferation","volume":"30","author":"Hu","year":"2011","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1124\/mol.105.021089","article-title":"A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells","volume":"70","author":"Kogan","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"153533","DOI":"10.1016\/j.phymed.2021.153533","article-title":"Efficacy of cannabinoids against glioblastoma multiforme: a systematic review","volume":"88","author":"Kyriakou","year":"2021","journal-title":"Phytomedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108865","DOI":"10.1016\/j.intimp.2022.108865","article-title":"Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells","volume":"108","author":"Lee","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.omto.2021.09.007","article-title":"Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R\/AKT\/GSK-3beta","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00520-025-09617-0","article-title":"Trends in cannabis use among those with and without a cancer diagnosis according to state-level cannabis policy: findings from the PATH study, waves 1-5 (2013-2019)","volume":"33","author":"Martin","year":"2025","journal-title":"Support Care Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"68781","DOI":"10.18632\/oncotarget.11968","article-title":"CB2 cannabinoid receptor activation promotes colon cancer progression via AKT\/GSK3beta signaling pathway","volume":"7","author":"Martinez-Martinez","year":"2016","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000355666","article-title":"Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer","volume":"59","author":"Oh","year":"2013","journal-title":"Chemotherapy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3892\/ijo_00000666","article-title":"The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells","volume":"37","author":"Patsos","year":"2010","journal-title":"Int. J. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"djv077","DOI":"10.1093\/jnci\/djv077","article-title":"Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer","volume":"107","author":"Perez-Gomez","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","article-title":"Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis","volume":"117","author":"Pisanti","year":"2011","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1096\/fj.02-1129fje","article-title":"Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis","volume":"17","author":"Portella","year":"2003","journal-title":"FASEB J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers14071769","article-title":"Impact of cannabinoid compounds on skin cancer","volume":"14","author":"Ramer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/mc.22451","article-title":"Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway","volume":"55","author":"Ravi","year":"2016","journal-title":"Mol. Carcinog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"39480","DOI":"10.1074\/jbc.M603495200","article-title":"Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1\/2 leading to G1 cell cycle arrest","volume":"281","author":"Sarfaraz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"119993","DOI":"10.1016\/j.lfs.2021.119993","article-title":"Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development","volume":"285","author":"Shoeib","year":"2021","journal-title":"Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1002\/cam4.6037","article-title":"Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K\/Akt\/mTOR signaling pathway","volume":"12","author":"Song","year":"2023","journal-title":"Cancer Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413328","article-title":"Gene expression data mining reveals the involvement of GPR55 and its endogenous ligands in immune response, cancer, and differentiation","volume":"22","author":"Wnorowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1660125","DOI":"10.3389\/fonc.2025.1660125","article-title":"Global, regional, and national burden of 34 cancer groups across 204 countries and territories, 1990-2021, and projections to 2050: a systematic analysis of the global Burden of Disease Study 2021","volume":"15","author":"Zhu","year":"2025","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1754350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:13:24Z","timestamp":1771924404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1754350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":33,"alternative-id":["10.3389\/fphar.2026.1754350"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1754350","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1754350"}}